A major Kentucky addiction treatment company is now at the center of a federal fraud investigation that raises urgent questions about oversight in the recovery industry. Tim Robinson, who built Addiction Recovery Care (ARC) into Kentucky's largest addiction treatment provider, pleaded not guilty on June 19 to three federal charges including wire fraud and money laundering. The case reveals how financial pressure and regulatory scrutiny can lead operators to allegedly divert funds meant for patient care toward keeping failing businesses afloat.

What Exactly Is ARC Accused Of?

Federal prosecutors allege that Robinson orchestrated a scheme to defraud lenders by selling the same Employee Retention Credits (ERC), a type of tax credit, to two separate companies. According to court documents, ARC sold these future tax credits across July, September, and November of 2025. When the Internal Revenue Service (IRS) paid out the credits in December, prosecutors claim Robinson redirected the money toward ARC's own operating costs instead of repaying either buyer. Robinson had reportedly assured one buyer in November that he had not already sold the assets elsewhere, making the alleged deception central to the fraud case.

The charges carry serious penalties. Wire fraud carries a maximum sentence of 20 years, while the two money laundering counts each carry up to 10 years. Robinson's trial is scheduled to begin in August. Until then, the court has barred him from opening new bank accounts or liquidating any assets.

How Did a Major Treatment Provider End Up in This Situation?

ARC's legal troubles did not emerge overnight. The company has faced mounting scrutiny since 2024, when the Federal Bureau of Investigation (FBI) began investigating it over alleged Medicaid billing fraud. That investigation continues today. A federal whistleblower lawsuit accused ARC of improperly billing Medicaid for psychoeducation sessions, which are supposed to be clinical treatment but reportedly fell short of genuine therapeutic value.

The financial exposure was staggering. Between 2023 and 2024, ARC received approximately $70 million in Medicaid payments under the psychoeducation billing code alone. That figure represents one in every five dollars paid nationally under the same code over those two years, a striking concentration for a single provider. As regulatory pressure mounted, ARC attempted to sell its assets to another treatment operator in 2025, but that deal collapsed at the start of 2026.

Soon after the failed sale, lenders began filing lawsuits. Angelica Capital Trust sued ARC in a New York federal court over a defaulted $5.4 million loan that ARC had promised to repay using incoming tax credits. Several other lenders have since filed similar lawsuits, each alleging the same pattern: ARC sold future tax credits, then never made the promised repayment. Court filings also referenced a draft settlement worth approximately $27.7 million between the Department of Justice and ARC over the psychoeducation billing allegations, showing just how much financial exposure the company faced.

Steps Regulators and Lawmakers Are Taking to Prevent Future Fraud

• Legislative Action: The Kentucky General Assembly passed legislation this year that bars Medicaid from paying claims for psychoeducation services. Republican state representative Kim Moser said providers had overbilled and abused the service to the tune of $300 million over five years, prompting lawmakers to eliminate the billing category entirely.
• Leadership Changes: Robinson resigned as ARC's chief executive once prosecutors handed down his indictment. A company spokesperson said ARC continues to operate, though the business has already closed most of its clinics since news of the FBI investigation broke.
• Ongoing Investigations: The FBI's investigation into ARC's Medicaid billing practices remains active. The outcome of Robinson's trial in August could shape how regulators police addiction treatment fraud across the country.

Why Does This Case Matter for Families Seeking Treatment?

Cases like ARC's highlight why families and regulators need to scrutinize addiction treatment providers closely. When operators allegedly divert funds meant for genuine recovery support to prop up failing businesses, the wider treatment sector loses credibility. Families searching for real help deserve confidence that the providers they turn to put recovery first, not just revenue.

The case also touches Kentucky's political landscape in ways that raise transparency concerns. Robinson has donated significant sums to figures across both major parties, including $195,000 to a group supporting Governor Andy Beshear's 2023 reelection campaign. He also donated to a political action committee backing Attorney General Russell Coleman, who has since recused himself from his office's investigation into ARC.

As the addiction treatment industry continues to grow, cases like this underscore the importance of robust financial oversight and clinical accountability. Patients and their families should ask treatment providers about their funding sources, billing practices, and regulatory history before enrolling. The August trial will provide more clarity on how deep ARC's financial misconduct ran and what consequences follow.